EPHA2 and cancer: To determine whether the elevated level of exosomal EphA2 in plasma correlated with the prognosis of cancer patients, we collected circulating exosomes in the plasma of healthy donors and breast cancer patients (with or without chemotherapy), and then the level of the exosomal EphA2 was investigated using the ELISA method.